| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07587697 A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-04 | NCT07587697 A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults… |
Enrollment reduced: 30 -> 15 participants |
| 2026-05-23 | NCT07587697 A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07624357 Bioequivalence Study of Vortioxetine in 20 mg Coated Tablets in Healthy Subjects Under… | Phase 1 | Completed |
| 2026-05-14 | NCT07587697 A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults… | Phase 1 | Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05489523 | Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With… | Transthyretin Cardiac Amyloidosis | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05552157 | A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a… | Alzheimers Disease | Recruiting |
| NCT06647498 | A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a… | Alzheimers Disease | Recruiting |
| Phase 1 | |||
| NCT07422285 | Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body… | Healthy Participants | Recruiting |
| NCT07470866 | A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults… | Healthy | Recruiting |
| NCT07346495 | A Study of Remternetug (LY3372993) in Healthy Chinese Participants | Healthy | Active, Not Recruiting |
| NCT07545226 | Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body… | Healthy Participants | Not Yet Recruiting |
| NCT07587697 | A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults… | Healthy Adults | Active, Not Recruiting |
| Not specified | |||
| NCT04801329 | Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin… | ATTR-CM (Transthyretin Amyloid Cardiomyopathy) | Active, Not Recruiting |